Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 17, 2026

Glycan Node Analysis: A Bottom-up Approach to Glycomics
11:36

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Published on: May 22, 2016

Commercial interest grows in glycan analysis

Cormac Sheridan

    Nature Biotechnology
    |February 9, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Immunoglobulin G N-Glycan Analysis by Ultra-Performance Liquid Chromatography
    11:01

    Immunoglobulin G N-Glycan Analysis by Ultra-Performance Liquid Chromatography

    Published on: January 18, 2020

    Related Experiment Videos

    Last Updated: Jul 17, 2026

    Glycan Node Analysis: A Bottom-up Approach to Glycomics
    11:36

    Glycan Node Analysis: A Bottom-up Approach to Glycomics

    Published on: May 22, 2016

    Immunoglobulin G N-Glycan Analysis by Ultra-Performance Liquid Chromatography
    11:01

    Immunoglobulin G N-Glycan Analysis by Ultra-Performance Liquid Chromatography

    Published on: January 18, 2020

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AI-powered methods shake up animal testing.

    Nature biotechnology·2026
    Same author

    Thymus renaissance poised to boost health and longevity.

    Nature biotechnology·2026
    Same author

    Historic FDA approval brings first gene therapy for genetic deafness.

    Nature biotechnology·2026
    Same author

    EU pushes for broad changes to biotech rules as China gains ground.

    Nature biotechnology·2026
    Same author

    Now with oligos: antibody-oligonucleotide conjugates are the new drug modality to watch.

    Nature biotechnology·2026
    Same author

    FDA approves new mechanism to treat idiopathic pulmonary fibrosis, expanding limited arsenal.

    Nature biotechnology·2025